Dr. Nanette F. Santoro, MD

Dr. Santoro practices at Uchealth Ccmc Infusion Outpatient - Chemotherapy - HOPD in Denver, Colorado.

Dr. Santoro's NPI, 1811077233, was assigned on October 17, 2006. Dr. Santoro graduated from Albany Medical College in 1979. Dr. Santoro holds Colorado license 48447.

Dr. Santoro's primary practice is Uchealth Ccmc Infusion Outpatient - Chemotherapy - HOPD, at 100 Cook St, Denver, CO 80206.

Dr. Santoro's primary practice is Uchealth Ccmc Infusion Outpatient - Chemotherapy - HOPD in Denver, Colorado. Dr. Santoro is also affiliated with UCHealth University of Colorado Hospital. The medical group on file is University of Colorado Medicine (CU Medicine). Dmand AI also links Dr. Santoro to 1 more ambulatory surgery center, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Santoro practices, 3 sites in all. Vendor and product names are available with a free account.

Reproductive endocrinology is Dr. Santoro's primary specialty in the NPI Registry, under taxonomy code 207VE0102X. Dr. Santoro is board certified in obstetrics & gynecology by the American Board of Obstetrics and Gynecology. Dmand AI has Dr. Santoro's licenses on file in 3 states: Colorado, New York and New Jersey.

Dmand AI lists menopause among the conditions Dr. Santoro treats.

CMS data shows 15 Medicare services from Dr. Santoro across 1 procedure code in 2024, all of them office visits, for 29 Medicare patients. Medicare paid $1,447 for them. Every service was in an office.

CMS counts 29 Medicare patients who saw Dr. Santoro in 2024. The largest group is 65 to 74, with 17 patients. 52% of them have arthritis, and 52% have high cholesterol. Their average risk score is 1.05, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Santoro's median patient age at 53, with 98% women.

In 2024, Dr. Santoro wrote 129 Medicare Part D claims for 33 patients. 73% of them were for generic drugs. CMS names the drug for 56 of them, across 4 drugs with 11 or more claims each, at $22,428 in total drug cost. In 2023, CMS named 37 claims across 3 drugs.

Dr. Santoro accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Santoro as offering telehealth.

Dmand AI links 385 papers to Dr. Santoro, published from 2005 to 2025. 2024 was the busiest year, with 21. The most frequent topics are Menopause, Infertility, Female and Follicle Stimulating Hormone. Dr. Santoro has published most often in Fertil Steril. Dr. Santoro's most frequent co-authors are Richard S. Legro, MD, Christos Coutifaris, MD and Esther Eisenberg, MD, MPH.

Dmand AI links Dr. Santoro to 13 clinical trials, 5 of them phase 3 studies. 1 is still active or recruiting. Conditions studied include Infertility, Genital Diseases and Coronary Disease. Yale University sponsors the most, 8.

CMS Open Payments shows 42 general payments to Dr. Santoro from 14 drug and device companies from 2018 to 2025. Consulting fees make up the largest share, 78% of the total. Astellas Pharma US Inc paid the most, $16,985. It also lists 15 research payments totaling $8,313 in 2023.

Dmand AI lists 6 awards for Dr. Santoro, most recently Outstanding Mentor Award in 2016.

Dr. Santoro graduated from Albany Medical College in 1979. Dr. Santoro is a member of AOA, American College of Obstetricians and Gynecologists, AMA, ASRM, ENDO and NAMS.

Dr. Santoro is in network with 17 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.